Evidence map›Paper›PMID 35904524›Full record

ArticleAnalytical and bioanalytical chemistry2022

From target analysis to suspect and non-target screening of endocrine-disrupting compounds in human urine.

Mikel Musatadi, Claudia Caballero, Leire Mijangos, Ailette Prieto, Maitane Olivares, Olatz Zuloaga

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mikel MusatadiDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain. mikel.musatadi@ehu.eus.ORCID http://orcid.org/0000-0002-8328-5181
Claudia CaballeroDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain.
Leire MijangosDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain.
Ailette PrietoDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain.
Maitane OlivaresDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain.
Olatz ZuloagaDepartment of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain.
University of the Basque Country · ES

Funding

Eusko Jaurlaritza IT1213-19Ministerio de Ciencia e Innovación PID2020-117686RB-C31
6 · The paper itself

Abstract

In the present work, a target analysis method for simultaneously determining 24 diverse endocrine-disrupting compounds (EDCs) in urine (benzophenones, bisphenols, parabens, phthalates and antibacterials) was developed. The target analysis approach (including enzymatic hydrolysis, clean-up by solid-phase extraction and analysis by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)) was optimized, validated and applied to volunteers' samples, in which 67% of the target EDCs were quantified. For instance, benzophenone-3 (0.2-13 ng g

Indexed as

Endocrine DisruptorsTandem Mass SpectrometryBenzhydryl CompoundsChromatography, LiquidHumansParabensSolid Phase ExtractionBenzhydryl CompoundsEndocrine DisruptorsParabensEndocrine-disrupting compoundsHigh-resolution tandem mass spectrometryLiquid chromatography tandem mass spectrometrySuspect and non-target screeningTarget analysis

Identifiers

PMID35904524
PMCPMC9436830
OpenAlexW4288697346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.